Sawai Group Holdings Co., Ltd. (4887.T)
JPY 2043.5
(-0.02%)
JPY 2043.5
(-0.02%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 82.89 Billion JPY | 13.34% |
| 2022 | 73.13 Billion JPY | 9.56% |
| 2021 | 66.74 Billion JPY | -7.1% |
| 2020 | 71.85 Billion JPY | -6.29% |
| 2019 | 76.67 Billion JPY | -4.61% |
| 2018 | 80.38 Billion JPY | -5.8% |
| 2017 | 85.33 Billion JPY | 206.18% |
| 2016 | 27.86 Billion JPY | -12.82% |
| 2015 | 31.96 Billion JPY | 185.36% |
| 2014 | 11.2 Billion JPY | 29.17% |
| 2013 | 8.67 Billion JPY | -76.16% |
| 2012 | 36.37 Billion JPY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 91.17 Billion JPY | 9.99% |
| 2023 FY | 82.89 Billion JPY | 13.34% |
| 2023 Q1 | 94.08 Billion JPY | 28.65% |
| 2023 Q2 | 90.26 Billion JPY | -4.06% |
| 2023 Q4 | 82.89 Billion JPY | -7.31% |
| 2023 Q3 | 89.42 Billion JPY | -0.93% |
| 2022 Q1 | 75.47 Billion JPY | 13.07% |
| 2022 FY | 73.13 Billion JPY | 9.56% |
| 2022 Q4 | 73.13 Billion JPY | -1.17% |
| 2022 Q3 | 73.99 Billion JPY | -0.93% |
| 2022 Q2 | 74.69 Billion JPY | -1.03% |
| 2021 Q2 | 70.26 Billion JPY | -1.34% |
| 2021 Q1 | 71.21 Billion JPY | -2.9% |
| 2021 FY | 66.74 Billion JPY | -7.1% |
| 2021 Q4 | 66.74 Billion JPY | -3.81% |
| 2021 Q3 | 69.39 Billion JPY | -1.24% |
| 2020 Q1 | 75.42 Billion JPY | -3.79% |
| 2020 FY | 71.85 Billion JPY | -6.29% |
| 2020 Q4 | 73.34 Billion JPY | 0.18% |
| 2020 Q2 | 74.27 Billion JPY | -1.52% |
| 2020 Q3 | 73.21 Billion JPY | -1.43% |
| 2019 Q3 | 77.85 Billion JPY | -1.41% |
| 2019 Q1 | 80.2 Billion JPY | 0.44% |
| 2019 Q2 | 78.97 Billion JPY | -1.54% |
| 2019 Q4 | 78.39 Billion JPY | 0.69% |
| 2019 FY | 76.67 Billion JPY | -4.61% |
| 2018 Q3 | 82.55 Billion JPY | -1.43% |
| 2018 FY | 80.38 Billion JPY | -5.8% |
| 2018 Q4 | 79.85 Billion JPY | -3.27% |
| 2018 Q2 | 83.75 Billion JPY | -1.35% |
| 2018 Q1 | 84.9 Billion JPY | -0.18% |
| 2017 Q4 | 85.05 Billion JPY | -22.99% |
| 2017 FY | 85.33 Billion JPY | 206.18% |
| 2017 Q1 | 139.95 Billion JPY | 405.79% |
| 2017 Q2 | 139.65 Billion JPY | -0.21% |
| 2017 Q3 | 110.44 Billion JPY | -20.92% |
| 2016 Q3 | 29.67 Billion JPY | -1.63% |
| 2016 Q2 | 30.16 Billion JPY | -1.44% |
| 2016 FY | 27.86 Billion JPY | -12.82% |
| 2016 Q4 | 27.67 Billion JPY | -6.76% |
| 2016 Q1 | 30.6 Billion JPY | 3.53% |
| 2015 Q2 | 22.5 Billion JPY | -3.05% |
| 2015 FY | 31.96 Billion JPY | 185.36% |
| 2015 Q4 | 29.56 Billion JPY | -7.06% |
| 2015 Q3 | 31.81 Billion JPY | 41.35% |
| 2015 Q1 | 23.21 Billion JPY | 107.2% |
| 2014 Q1 | 9.66 Billion JPY | 11.44% |
| 2014 Q2 | 9.01 Billion JPY | -6.74% |
| 2014 Q3 | 8.43 Billion JPY | -6.42% |
| 2014 Q4 | 11.2 Billion JPY | 32.82% |
| 2014 FY | 11.2 Billion JPY | 29.17% |
| 2013 FY | 8.67 Billion JPY | -76.16% |
| 2013 Q4 | 8.67 Billion JPY | 54.3% |
| 2013 Q3 | 5.62 Billion JPY | -76.28% |
| 2013 Q2 | 23.7 Billion JPY | -36.48% |
| 2013 Q1 | 37.31 Billion JPY | 2.57% |
| 2012 Q3 | - JPY | 0.0% |
| 2012 Q4 | 36.37 Billion JPY | 0.0% |
| 2012 Q2 | - JPY | 0.0% |
| 2012 FY | 36.37 Billion JPY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 16.89 Billion JPY | -390.735% |
| Takeda Pharmaceutical Company Limited | 4843.75 Billion JPY | 98.289% |
| Sumitomo Pharma Co., Ltd. | 418.88 Billion JPY | 80.212% |
| Shionogi & Co., Ltd. | 11.62 Billion JPY | -613.339% |
| Wakamoto Pharmaceutical Co.,Ltd. | 100.52 Million JPY | -82353.819% |
| Nippon Shinyaku Co., Ltd. | 2.87 Billion JPY | -2786.142% |
| Kaken Pharmaceutical Co., Ltd. | 3.85 Billion JPY | -2052.987% |
| Eisai Co., Ltd. | 206.74 Billion JPY | 59.907% |
| Morishita Jintan Co., Ltd. | 425 Million JPY | -19403.529% |
| Hisamitsu Pharmaceutical Co., Inc. | 2.1 Billion JPY | -3847.143% |
| Mochida Pharmaceutical Co., Ltd. | 369 Million JPY | -22363.415% |
| Fuso Pharmaceutical Industries,Ltd. | 12.72 Billion JPY | -551.548% |
| Nippon Chemiphar Co., Ltd. | 16.98 Billion JPY | -388.134% |
| Tsumura & Co. | 79.69 Billion JPY | -4.016% |
| Kissei Pharmaceutical Co., Ltd. | 1.72 Billion JPY | -4699.653% |
| Torii Pharmaceutical Co., Ltd. | 244 Million JPY | -33871.311% |
| Towa Pharmaceutical Co., Ltd. | 202.35 Billion JPY | 59.038% |
| Fuji Pharma Co., Ltd. | 28.94 Billion JPY | -186.341% |
| Zeria Pharmaceutical Co., Ltd. | 47.58 Billion JPY | -74.19% |
| KYORIN Holdings, Inc. | 20.94 Billion JPY | -295.732% |
| Taiko Pharmaceutical Co.,Ltd. | 3.8 Billion JPY | -2076.162% |
| Daito Pharmaceutical Co.,Ltd. | 8.71 Billion JPY | -850.682% |
| SymBio Pharmaceuticals Limited | - JPY | -Infinity% |
| MedRx Co., Ltd | - JPY | -Infinity% |
| Mizuho Medy Co.,Ltd. | - JPY | -Infinity% |
| Solasia Pharma K.K. | 60 Million JPY | -138050.0% |
| Modalis Therapeutics Corporation | 412.5 Million JPY | -19994.545% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 9.48 Billion JPY | -773.906% |
| Cyfuse Biomedical K.K. | 913 Million JPY | -8978.861% |
| Toho Holdings Co., Ltd. | 30.24 Billion JPY | -174.071% |
| Koa Shoji Holdings Co.,Ltd. | 2.82 Billion JPY | -2833.86% |